NMO SPECTRUM DISORDER

Clinical trials for NMO SPECTRUM DISORDER explained in plain language.

Never miss a new study

Get alerted when new NMO SPECTRUM DISORDER trials appear

Sign up with your email to follow new studies for NMO SPECTRUM DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1

CAR-T therapy for autoimmune diseases: study pulled before start

Disease control Terminated

This study was designed to test a new CAR-T cell treatment for several autoimmune diseases, including lupus and multiple sclerosis. The goal was to see if the therapy was safe and could help control symptoms. However, the study was withdrawn before any participants were enrolled.

Matched conditions: NMO SPECTRUM DISORDER

Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control

Last updated Jun 15, 2026 19:06 UTC

NMO SPECTRUM DISORDER

Get alerted when new NMO SPECTRUM DISORDER trials appear

CAR-T therapy for autoimmune diseases: study pulled before start